Clinical Trial Update: Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated how BIA 9-1067 affects the pharmacokinetics of Levodopa in Parkinson's disease; the trial completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067
• levodopa (levodopa)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2015-08-20